The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

as the presentation is indistinguishable from other respiratory tract infections, and epidemics often overlap. The microbiologic confirmation of RSV infection is based on detecting the virus in a ...

flu and Respiratory syncytial virus (RSV). Dr. Elaine Perry, Director of the Richmond and Henrico Health Districts, clarified ...

2024 — This multi-state study is a real world data analyses of the effectiveness of the RSV -- short for respiratory syncytial virus -- vaccine. VISION ... Nov. 7, 2024 — Increased ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Immunoassays for assessing prevalence are unsuitable for assessing incidence. Detection of IgM antibody or p24 antigen is unsuitable for HIV incidence testing. None of the available incidence ...

Sep. 26, 2024 — What factors lead to chronic respiratory disease? Researchers investigated this question using health data from about 780 infants. Their analysis shows that children's risk of ...

It is an illness that occurs primarily in children younger than 2 years old. It most commonly occurs in babies between 3 and 6 months old, with respiratory syncytial virus (RSV) being the primary ...

Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the bronchi and the lungs. They range from acute infections, such as ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...